Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;26(1):182-98.
doi: 10.1353/hpu.2015.0009.

Prescription practices involving opioid analgesics among Americans with Medicaid, 2010

Prescription practices involving opioid analgesics among Americans with Medicaid, 2010

Karin A Mack et al. J Health Care Poor Underserved. 2015 Feb.

Abstract

Recent state-based studies have shown an increased risk of opioid overdose death in Medicaid populations. To explore one side of risk, this study examines indicators of potential opioid inappropriate use or prescribing among Medicaid enrollees. We examined claims from enrollees aged 18-64 years in the 2010 Truven Health MarketScan® Multi-State Medicaid database, which consisted of weighted and nationally representative data from 12 states. Pharmaceutical claims were used to identify enrollees (n=359,368) with opioid prescriptions. Indicators of potential inappropriate use or prescribing included overlapping opioid prescriptions, overlapping opioid and benzodiazepine prescriptions, long acting/extended release opioids for acute pain, and high daily doses. In 2010, Medicaid enrollees with opioid prescriptions obtained an average 6.3 opioid prescriptions, and 40% had at least one indicator of potential inappropriate use or prescribing. These indicators have been linked to opioid-related adverse health outcomes, and methods exist to detect and deter inappropriate use and prescribing of opioids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Opioid prescriptions drawn from pharmaceutical claims flow chart.

Similar articles

Cited by

References

    1. Paulozzi LJ. Prescription drug overdoses: a review. J Safety Res. 2012 Sep;43(4):283–89. http://dx.doi.org/10.1016/j.jsr.2012.08.009. - DOI - PubMed
    1. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013 Feb;309(7):657–9. http://dx.doi.org/10.1001/jama.2013.272. - DOI - PubMed
    1. Quality CfBHSa, editor. Substance Abuse and Mental Health Services Administration. The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. - PubMed
    1. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166–75. http://dx.doi.org/10.1002/pds.1833. - DOI - PMC - PubMed
    1. Von Korff M, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008 Jul-Aug;24(6):521–7. http://dx.doi.org/10.1097/AJP.0b013e318169d03b. - DOI - PMC - PubMed

Substances

LinkOut - more resources